다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Rigel Pharmaceuticals Inc (RIGL)
Rigel Pharmaceuticals Inc (RIGL) 뉴스

RIGL

Rigel Pharmaceuticals (RIGL)

Rigel Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RIGL

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/01	08:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/02/01	08:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/02/01	08:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/02/01	08:47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/29	10:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/25	06:38	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/22	22:05	PR Newswire (US)	Rigel's Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/13	22:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/13	22:05	PR Newswire (US)	Rigel Provides Business Update and 2025 Outlook	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/09	22:05	PR Newswire (US)	Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/08	22:05	PR Newswire (US)	Rigel to Present at the 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2025/01/03	22:05	PR Newswire (US)	Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/12/10	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/12/10	02:02	PR Newswire (US)	Rigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/12/02	22:05	PR Newswire (US)	Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/27	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/27	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/27	10:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/15	07:18	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/15	05:33	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/12	22:05	PR Newswire (US)	Rigel to Present at the Jefferies London Healthcare Conference	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/08	06:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/08	06:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/08	06:01	PR Newswire (US)	Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/11/05	23:05	PR Newswire (US)	Rigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and Exposition	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/10/31	21:05	PR Newswire (US)	Rigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business Update	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/10/25	05:35	PR Newswire (US)	Rigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/10/16	23:00	GlobeNewswire Inc.	Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/10/04	21:05	PR Newswire (US)	Rigel Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:RIGL	Rigel Pharmaceuticals Inc
2024/09/20	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RIGL	Rigel Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:RIGL

1 2 3 4 5 6 7 8 9 10 다음 >>

Invesco QQQ Trust Series 1

Bank of America

BNP Paribas (QX)

Health Care Select Sector

Energy Select Sector SPDR

Verizon Communications

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관